Key facts
- This page summarizes Eric Drape's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
- 4 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 05 Mar 2024, 16:25.
Eric Drape - 03 Mar 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Signature
- /s/ Dov Bergwerk as attorney-in-fact for Eric Drape
- Issuer symbol
- TEVA
- Transactions as of
- 03 Mar 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 05 Mar 2024, 16:25:00 UTC
- Previous filing
- 01 Mar 2024
- Next filing
- 07 Mar 2024
- SEC
- View on sec.gov
Key filing fact
Eric Drape filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 05 Mar 2024.
Change
- Previous filing in this sequence was filed on 01 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +24,900
- Change %
- +128%
- Price
- Shares after
- 44,416
- Date
- 03 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +33,512
- Change %
- +75%
- Price
- Shares after
- 77,928
- Date
- 04 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -24,900
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 74,701
- Date
- 03 Mar 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 24,900
- Exercise price
- Footnotes
- F1, F2, F3
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -33,512
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 67,024
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 33,512
- Exercise price
- Footnotes
- F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| F2 | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| F3 | Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. |
| F4 | Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026. |